Combined treatments appear more effective than any one drug or chemotherapy alone against HER-2 tumors, researchers report
Filed under: Noticias | Tagged: Bloomberg Business Week, BreastCancer, Her-2: The Making of Herceptin a Revolutionary Treatment for Breast Cancer, HER2/neu, Herceptin, Lapatinib, Massachusetts General Hospital, Pertuzumab, Trastuzumab | Leave a Comment »
